1 / 30

Role of Clinical Pharmacist in Psychiatry

Role of Clinical Pharmacist in Psychiatry. Alam Sher, PharmD, MBA MHC Cl. Pharmacist, Togus VAMC, Augusta, Maine Adj. Assoc. Prof. Pharmacy Practice, MCPHS, Boston, Mass Cl. Assoc. Prof. Family Med. (Psychiatry), UNE Col Of Osteopath Medicine

more
Télécharger la présentation

Role of Clinical Pharmacist in Psychiatry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Role of Clinical Pharmacist in Psychiatry Alam Sher, PharmD, MBA MHC Cl. Pharmacist, Togus VAMC, Augusta, Maine Adj. Assoc. Prof. Pharmacy Practice, MCPHS, Boston, Mass Cl. Assoc. Prof. Family Med. (Psychiatry), UNE Col Of Osteopath Medicine HEC Visiting Scholar, IslamiaUni of Bahawalpur, Pakistan President, NA Sher Foundation for Health, Education & Humanities www.sherfoundation.org - Wikipedia Article: Nasreen & Alam Sher Foundation

  2. Road Map • Definitions • Psychiatry / Mental Health • Psychiatric Pharmacist • History of Psychiatric Pharmacy • Is there a need for it? • What Does a Psychiatric Pharmacist Do? • Psychiatric Pharmacist Skills • Assessment and Interview Skills • Comprehensive Medication History • Literature Review • Other Notable References • Q/A

  3. Psychiatry or Mental Health • Psychiatry is devoted to the study and treatment of mental disorders. These mental disorders include various affective, behavioral, cognitive and perceptual abnormalities. • The term was first coined by the German physician Johann Christian Reil in 1808, and literally means the 'medical treatment of the mind' (psych-: mind; from Ancient Greek psykhē: soul; -iatry: medical treatment; from Gk. iātrikos: medical, iāsthai: to heal). Wikipedia - 2011

  4. The Psychiatric Pharmacist • PharmD with relevant clinical experience in Psychiatry • Additional residency and fellowship in psychiatric medication use • Board certified in psychiatric pharmacy • Most work in academics, MH facilities, VA • Increasing interest in the Patient-Centered Medical Home (PCMH) C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  5. Brief History of Psychiatric Pharmacy Practice • For over 40 years, some pharmacists have specialized in psychiatric pharmacy • In 1992, the Board of Pharmacy Specialty recognized psychiatric pharmacy as a specialty of pharmacy • As of 2011, there are 627 board-certified pharmacists (BCPP) • In 1998, the College of Psychiatric and Neurologic Pharmacists (CPNP) was founded • In 2011, CPNP membership grew to 1,130 Glen Stimmel, PharmD, Manifesto - Psychiatric Pharmacy, CPNP

  6. Is there a need? • Mental/behavioral health problems are under diagnosed and often untreated • Untreated MH = more health care costs • Many of these conditions can be successfully treated in primary care • 80% of patients prefer to get their behavioral health care from their family doctor • Up to 70% of primary care visits have a behavioral health basis C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  7. Number of Physical Symptoms and Likelihood of Mental Illness 70% 50% 30% 10% 0-1 2-3 4-5 6-7 >8 Number of Physical Symptoms Frank deGruy (2010). Kentucky Policy Summit

  8. Fit in the PCMH • Fits with NCQA, HEDIS, ACO, NQF measures • Depression screening • Medication reconciliation • Hospital follow-up, care transitions • Develop care plans • Self-management goal setting • Care coordination • High-risk populations and medications • Evidence-based guidelines C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  9. What Does a Psychiatric Clinical Pharmacist Do? • Teach pharmacy, nursing, medical students/residents/practitioners • Lead medication education groups • Assist with formulary decision processes • Work collaboratively with teams to optimize pharmacotherapy • Provide direct patient care via assessment and medication management • Conduct research/publish • Patient advocacy The University of Texas Medical Branch at Galveston (UTMB) - CPNP - 2011

  10. Psychiatric Pharmacist Skills • Interview techniques • Comfort with patients with mental illnesses and their families • Measurement-based care • Evidence-based treatment guidelines • Access to affordable medications • Patient medication education • Team-based care • Referral to therapy, support C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  11. Assessment • Indication for use • Efficacy • Safety – adverse effects, drug interactions • Adherence • Comprehensive Medication Management

  12. Comprehensive Medication Management Defined • Meet with the patient and family or NOK, if needed, to help them identify their medication-related goals • Review all medications • Rx, OTC, supplements • Caffeine, tobacco, alcohol, illicit drugs • From all providers • As they actually take them • Obtain pertinent vital signs, labs especially UDS, TSH, Vit. B12, Folate, and Vit. D3 C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  13. Comprehensive Medication Management • Focus on medication use • Goal to prevent or identify and resolve medication-related problems • Referred to as Medication Therapy Management (MTM) by Medicare Part D • See Patient-Centered Primary Care Collaborative (PCPCC )Document developed by the Medication Management task force www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet_2010_06-2010_final.pdf www.pcpcc.net/files/medmanagement.pdf - 2010

  14. Comprehensive Medication Management (cont’d) • Identify medication-related problems • Untreated indications • Glucose, lipids, hypertension • Not meeting goals • Adverse effects, drug interactions • Adherence, Cost • Complete medication list to patient, provider • Care plan with recommendations to resolve problems to provider(s) • Follow-up with patient to assess outcomes C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  15. Meds Non-Adherence - Quotes for the Day “Drugs don’t work in patients who don’t take them.” - C. Everett Koop, M.D. The most expensive pill is that which is not taken or taken inappropriately.

  16. Model Programs • Federally Qualified Health Center (FQHC) in Billings, MT • Family Medicine Residency • Integrated behavioral health with PsyD and 2 mental health/addiction counselors • Integrated medication management with PharmD, pharmacy residents and students • Available for brief interventions in clinic daily • Longer appointments can be scheduled for comprehensive medication assessments C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  17. North Carolina Medicaid • Currently have “generalist” pharmacists imbedded in selected practices • Pharmacists involved in medication reconciliation for all Medicaid patients entering hospital • “Boot-camp” training on behavioral health medications ongoing • Assess impact of training on outcome metrics C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  18. 2010 Medicare Part D Medication Therapy Management (MTM) Programs www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet_2010_06-2010_final.pdf Accessed 11/11

  19. Reimbursement • Varies by state • Pharmacy schools • Medicare Part D • Employers • Medicaid in some states • New payment structures???

  20. Medication Management Services: Resource-Based Relative Value Scale Source: Minnesota Department of Human Services, MHCP Provider Manual, Medication Management Therapy Services, - HIPAA– Compliant MTMS CPT Codes, Revised 1/5/2010. Accessed 11/11

  21. Value • Return on investment varies, average 5:1 • Improves patient outcomes • Improves access to care • Decreases resource utilization, admissions • Improves patient satisfaction • May increase drug spend • Untreated indications, adherence improves • Decreases overall cost C. Cobb and J. McKee of The Col. of Psychiatric and Neurologic Pharmacists (CPNP) - 2011

  22. Bond et al • Intervention: Drug monitoring • Pt population: Schizophrenia • Study design: Retrospective chart review • Study duration: 1 year • N = 25 • Results: ↓ in hospital readmissions (42 vs 3), ↓ in AEs reported (38 vs 4), 39% ↓ in fluphenazine dosage requirements, 42% ↓ in anticholinergic use AE = Adverse Effect Bond et al. J Clin Psychiatry 1979;40:501-3.

  23. Gray et al • Intervention: Treatment recommendations b/f clinic visit & education to pts • Pt population: Various • Study design: Retrospective chart review • Study duration: 3 months • N = 19 • Results: ↓ in AEs reported (61 vs 20), ↓ of 1.32 meds/pt/month, improvement in pt’s drug knowledge score (53% vs 77%) Gray et al. Contemp Pharm Pract 1979;2:108-16.

  24. Lobeck et al • Intervention: Drug monitoring & weekly groups • Pt population: Undisclosed • Study design: Retrospective chart review & provider satisfaction survey • Study duration: 3 months • N = Unknown (total of 4734 visits b/f intervention & 2662 visits after) • Results: 66% of recommendations were implemented, very favorable provider response to survey (4.41 on a 1-5 scale), saved $22,241 Lobeck et al. Hosp Commun Psychiatry 1989;40:643-4.

  25. Lee et al • 600 VA pharmacist recommendations reviewed • 92% were accepted by providers • Improved clinical outcomes in >30% • Avoided harm in 90% • Total cost avoidance = $420,155 Lee et al. Am J Health-Syst Pharm 2002;59:2070-7.

  26. ACCP Task Force • Evidence of economic benefit of clinical pharmacy services: 1996-2000 • No. of studies = 59 (12 were VA) • 100% demonstrated positive findings • Benefit:cost ratio range = 1.74:1 – 17.0:1 (median = 4.68:1) Schumock et al. Pharmacotherapy 2003;23:113-32.

  27. Other Notable Publications • JH Colman, III, RL Evans and SA Rosenbluth. “Extended clinical roles for the pharmacist in psychiatric care”; AJHP, 30:1143-1146 (Dec) 1973 • KK Roe, JA Doheide, and MZ Wincor. “Developing a Partnership With NAMI and Psychiatric Pharmacists”; Schizophrenia Bulletin, 28 (3), 2002 • N Sanghera, PO chan, ZF Khaki, Claire Planner, KKC Lee, NE Cranswick, and ICK Wong. “Interventions of hospital Pharmacists in Improving Drug Therapy in Children”; Drug Society 29(11): 1031-1047, 2006 • P Tait, and D Hall. “Pharmacy Involvement on a Psychiatric Unit at St. Paul’s Hospital”; The Canadian Journal of Hospital Phramacy, Vol XXXI, Nov-Dec, 1978 • GL Ellenor, and BR Dishman. “Pharmaceutical Care Role Model in Psychiatry-Pharmcist Prescribing”; Hosp Pharm, 30(5):371-373, 377-378, 1995 • MH Jenkins, and CA Bond. “The Impact of Clinical Pharmacists on Psychiatric Patients”; Pharmacotherapy, 16(4): 708-714, 1996 • WA Morton, AR Mendenhall, PG Windsor, B Lydiard. “Clinical Psychopharmacy Cosultations: Acceptance of Recommendations on an Adult Inpatient Psychiatric Unit”; Hosp Pharm, 30(9), 786-790, 1995 • CA O’Reilly, JS Bell, and TF Chen. “Pharmacists’ beliefs about Treatment and Outcomes of Mental Disorders: “A Mental Health Literacy Survey”; Aust N Z J Psychiatry 44: 1089-1096, 2010 • JE Duga, AA Cardoni, and PG Pierpaoll. “Pharmacists Should Serve on Psychiatric Patients’ Units”; Hospitals, J.A.H.A., 49, Sept 16, 1975

  28. Summary • Pharmacist interventions improve: • Better Patient Care • Prescribing patterns • ↓ the dosage & absolute number of psychotropic drugs • ↓ the potential AE burden of the psychotropic agents administered • Access to prescribers • Cost-Effective • Patient and medication safety

  29. For every $1 invested in clinical pharmacy services, more than $4 in benefit is expected. . Schumock et al. Pharmacotherapy 2003;23:113-32.

  30. Thank you !Questions & Comments?

More Related